Gang Jian Wang

Gang Jian Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2023 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
GZGe Zhang
Ge Zhang
WMWunan Mi
Wunan Mi
CWChuyue Wang
Chuyue Wang
JLJiehan Li
Jiehan Li
YZYizheng Zhang
Yizheng Zhang
YZYingjie Zhang
Yingjie Zhang
Ferroptosis is a new type of iron-dependent programmed cell death induced by lipid peroxidation. However, the underlying mechanisms and function in tumor therapy still remain undisclosed especially in post-transcription regulation. Here, we found that targeting AKT significantly induced GPX4 dependent ferroptosis and suppressed colorectal cancer growth both in vitro and in vivo. During this process, demethylase FTO was downregulated, which increased the m6A methylation level of GPX4, subsequently recognized by YTHDF2 and degraded. Prediction results showed that there are three potential methylated sites (193/647/766), and 193 site was identified as the right one, which was demethylated by FTO and read by YTHDF2. In parallel, AKT inhibition caused the accumulation of ROS which had a negative feedback on GPX4 expression. In addition, protective autophagy was initiated by MK2206 stimulation, while blocking autophagy further increased ferroptosis and markedly enhanced the anti-tumor activity of MK2206. In a word, inhibiting AKT activated ferroptosis through FTO/YTHDF2/GPX4 axis to suppress colon cancer progression, which raised FTO/GPX4 as potential biomarkers and targets in colorectal cancer therapy.

5 January 2023 in Life Sciences
Verified
Journal Article
Open access
RSRui Shi
Rui Shi
GWGang Jian Wang
Gang Jian Wang
ZZZhen Zhang
Zhen Zhang
YLYiping Leng
Yiping Leng
ACAlex F Chen
Alex F Chen
Liver is a pivotal organ for sepsis-induced injury and approximately 40 % of liver injury results from sepsis. During hepatic injury, monocyte-to-macrophage differentiation is a key event because it results in the regulation of immune response. Asialoglycoprotein receptor 1 (ASGR1) is enriched in classical monocyte of peripheral blood mononuclear cells (PBMCs). We aimed to explore the effect of ASGR1 on monocyte-to-macrophage differentiation and the modulation of sepsis-induced liver injury. ASGR1-knockdown/overexpression THP-1 cells and mice bone marrow-derived macrophages (BMDMs) induced by PMA and 30 % L929-cell conditioned medium were utilized to test the impact of ASGR1 on monocyte-to-macrophage differentiation and molecular mechanism respectively. Expression of differentiation specific factors were assessed via flow cytometry and real-time quantitative PCR. RNA-sequencing (RNA-seq) analysis revealed the effect of ASGR1 on monocyte-to-macrophage differentiation. Further, differentiation specific factors ATF5 and NF-κB pathways were examined via Western blot. The interaction between ASGR1 and ATF5 was further examined by co-IP. Finally, LPS-induced ASGR1-knockdown mice sepsis was used to investigate the effect of ASGR1 on monocyte-to-macrophage differentiation, liver injury and survival. ASGR1 promoted monocyte-to-macrophage differentiation via up-regulating CD68, F4/80 and CD86. Additionally, inhibited-ASGR1 decreased ATF5 expression by suppressing phosphorylation of NF-κB and IKBa in vitro and in vivo. ASGR1-knockdown mice suppressed Ly6Chi inflammatory monocytes in PBMCs, and restrained CD45+CD11bhiF4/80+Ly6Clo monocyte-derived macrophages and CD45+CD11b+F4/80+Ly6C+ inflammatory macrophages in livers. It also suppressed the level of IL-1β, IL-6, TNF-α and alleviated liver injury and improved survival after sepsis. ASGR1 is a negative regulator for sepsis-induced liver injury and survival.

17 June 2022 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
YZYizheng Zhang
Yizheng Zhang
CZChuchu Zhang
Chuchu Zhang
JLJiehan Li
Jiehan Li
MJMeimei Jiang
Meimei Jiang
SGShuning Guo
Shuning Guo
YZYingjie Zhang
Yingjie Zhang
Background: Targeting AKT suppresses tumor growth through inducing apoptosis, however, during which whether other forms of cell death occurring is poorly understood.Methods: The effects of increasing PARP1 dependent cell death (parthanatos) induced by inhibiting AKT on cell proliferation were determined by CCK-8 assay, colony formation assay, Hoechst 33,258 staining and analysis of apoptotic cells by flow cytometry. For the detailed mechanisms during this process, Western blot analysis, qRT-PCR analysis, immunofluorescence and co-immunoprecipitation were performed. Moreover, the inhibition of tumor growth by inducing p53/SIRT6/PARP1-dependent parthanatos was further verified in the xenograft mouse model.Results: For the first time, we identified that inhibiting AKT triggered parthanatos, a new form of regulated cell death, leading to colon cancer growth suppression. For the mechanism investigation, we found that after pharmacological or genetic AKT inhibition, p53 interacted with SIRT6 and PARP1 directly to activate it, and promoted the formation of PAR polymer. Subsequently, PAR polymer transported to outer membrane of mitochondria and resulted in AIF releasing and translocating to nucleus thus promoting cell death. While, blocking PARP1 activity significantly rescued colon cancer from death. Furthermore, p53 deletion or mutation eliminated PAR polymer formation, AIF translocation, and PARP1 dependent cell death, which was promoted by overexpression of SIRT6. Meanwhile, reactive oxygen species production was elevated after inhibition of AKT, which might also play a role in the occurrence of parthanatos. In addition, inhibiting AKT initiated protective autophagy simultaneously, which advanced tumor survival and growth.Conclusion: Our findings demonstrated that AKT inhibition induced p53-SIRT6-PARP1 complex formation and the activation of parthanatos, which can be recognized as a novel potential therapeutic strategy for cancer.

1 September 2021 in Pulmonary Circulation
Verified
Journal Article
Open access
PDF file
YLYapei Li
Yapei Li
YLYing Li
Ying Li
LLLijun Li
Lijun Li
MYMinghui Yin
Minghui Yin
GWGang Jian Wang
Gang Jian Wang
XLXiaohui Li
Xiaohui Li
Pulmonary hypertension is a progressive fatal disease that currently has no specific therapeutic approaches. In this study, dsRNA‐dependent protein kinase (PKR) was considered a candidate molecule in pulmonary hypertension. We demonstrated that PKR is activated in the endothelium of experimental pulmonary hypertension models. Deletion of PKR or treatment with the PKR activation inhibitor C16 inhibited the development of pulmonary hypertension. To explore the mechanism of PKR in pulmonary hypertension, we detected its downstream signaling and found that PKR knockout represses apoptosis‐associated speck‐like protein containing CARD (ASC) activation to inhibit high mobility group box 1 (HMGB1) and interleukin‐1 beta release. To further explore whether ASC mediates the pro‐pulmonary hypertension role of PKR, we used ASC deletion mice and found that ASC deletion inhibits the development of pulmonary hypertension and the release of HMGB1 and interleukin‐1 beta. Furthermore, we co‐cultured pulmonary arterial endothelial cells (PAECs) and pulmonary arterial smooth muscle cells (PASMCs) and found that endothelial PKR promotes PASMCs proliferation through the release of HMGB1 and interleukin‐1 beta. In conclusion, these data indicate that endothelial PKR promotes the excessive proliferation of PASMCs by inducing ASC activation to release HMGB1 and interleukin‐1 beta, which lead to the development of pulmonary hypertension. Our study will provide a novel insight that PKR is a potential target in the future treatment of pulmonary hypertension.

20 May 2023 in SSM - Population Health
Verified
Journal Article
Open access
DTDait Ting
Dait Ting
GWGang Jian Wang
Gang Jian Wang
GGGang Gan
Gang Gan
CZChun Zhang
Chun Zhang
DQDong Xiao Qian
Dong Xiao Qian
YDYinglong Duan
Yinglong Duan
Our aim was to examine the associations between work intensity and depressive symptoms among the working population, as well as to identify the impact of physical activity (PA) on these relationships. Spearman correlation analysis was conducted to analyze the correlations among work intensity, PA, and depressive symptoms. Working hours and working days were positively correlated with depressive symptoms (r = 0.108, 0.063; all p values were <0.001). Regular PA, exercise time, exercise frequency, and exercise years were negatively correlated with depressive symptoms (r = −0.121, −0.124, −0.152, −0.149; all p values were <0.001) and working days (r = −0.066, −0.050, −0.069, −0.044; all p values were <0.001), working hours (r = −0.113. −0.106, −0.161, −0.123; all p values were <0.001). Working days was positively correlated with working hours (r = 0.512, p < 0.001). Different levels of PA alleviated the effect of working hours or working days on depressive symptoms. Working hours seemed to be more correlated with depressive symptoms than working days. The results suggest that PA at any level could buffer against the effects of work intensity and might prove a helpful strategy for improving mental health issues among employees.

13 June 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
TPTing Peng
Ting Peng
RMRujia Miao
Rujia Miao
HXHao Xiong
Hao Xiong
YLYanhui Lin
Yanhui Lin
DFDuzhen Fan
Duzhen Fan
JCJianwen Chen
Jianwen Chen
Background: Insulin resistance (IR), a precursor to type 2 diabetes and a major risk factor for various chronic diseases, is becoming increasingly prevalent in China due to population aging and unhealthy lifestyles. Current methods like the gold-standard hyperinsulinemic-euglycemic clamp has limitations in practical application. The development of more convenient and efficient methods to predict and manage IR in nondiabetic populations will have prevention and control value. Objective: This study aimed to develop and validate a machine learning prediction model for IR in a nondiabetic population, using low-cost diagnostic indicators and questionnaire surveys. Methods: A cross-sectional study was conducted for model development, and a retrospective cohort study was used for validation. Data from 17,287 adults with normal fasting blood glucose who underwent physical exams and completed surveys at the Health Management Center of Xiangya Third Hospital, Central South University, from January 2018 to August 2022, were analyzed. IR was assessed using the Homeostasis Model Assessment (HOMA-IR) method. The dataset was split into 80% (13,128/16,411) training and 20% (32,83/16,411) testing. A total of 5 machine learning algorithms, namely random forest, Light Gradient Boosting Machine (LightGBM), Extreme Gradient Boosting, Gradient Boosting Machine, and CatBoost were used. Model optimization included resampling, feature selection, and hyperparameter tuning. Performance was evaluated using F 1 -score, accuracy, sensitivity, specificity, area under the curve (AUC), and Kappa value. Shapley Additive Explanations analysis was used to assess feature importance. For clinical implication investigation, a different retrospective cohort of 20,369 nondiabetic participants (from the Xiangya Third Hospital database between January 2017 and January 2019) was used for time-to-event analysis with Kaplan-Meier survival curves. Results: Data from 16,411 nondiabetic individuals were analyzed. We randomly selected 13,128 participants for the training group, and 3283 participants for the validation group. The final model included 34 lifestyle-related questionnaire features and 17 biochemical markers. In the validation group, their AUC were all greater than 0.90. In the test group, all AUC were also greater than 0.80. The LightGBM model showed the best IR prediction performance with an accuracy of 0.7542, sensitivity of 0.6639, specificity of 0.7642, F 1 -score of 0.6748, Kappa value of 0.3741, and AUC of 0.8456. Top 10 features included BMI, fasting blood glucose, high-density lipoprotein cholesterol, triglycerides, creatinine, alanine aminotransferase, sex, total bilirubin, age, and albumin/globulin ratio. In the validation queue, all participants were separated into the high-risk IR group and the low-risk IR group according to the LightGBM algorithm. Out of 5101 high-risk IR participants, 235 (4.6%) developed diabetes, while 137 (0.9%) of 15,268 low-risk IR participants did. This resulted in a hazard ratio of 5.1, indicating a significantly higher risk for the high-risk IR group. Conclusion: By leveraging low-cost laboratory indicators and questionnaire data, the LightGBM model effectively predicts IR status in nondiabetic individuals, aiding in large-scale IR screening and diabetes prevention, and it may potentially become an efficient and practical tool for insulin sensitivity assessment in these settings.